Início › Câncer de Próstata › Michigan › Detroit
Ensaios clínicos de Câncer de Próstata em Detroit, MI
22 estudos para Câncer de Próstata estão buscando participantes em locais em Detroit e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
The Vanguard Study: Testing a New Way to Screen for Cancer
RecrutandoVoluntários saudáveis bem-vindos
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
RecrutandoFase 3
- Henry Ford Hospital, Detroit
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecrutandoFase 2
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RecrutandoFase 3
- Henry Ford Hospital ( Site 0015), Detroit
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
RecrutandoFase 1/2
- Research Site, Detroit
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecrutandoFase 1
- Barbara Ann Karmanos Cancer Institute, Detroit
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RecrutandoFase 3
- Karmanos Cancer Institute, Detroit
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RecrutandoFase 3
- Henry Ford Hospital ( Site 0035), Detroit
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Recrutando
- Wayne State University, Detroit
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecrutandoFase 3
- Henry Ford Hospital, Detroit
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
RecrutandoFase 1/2
- Karmanos Cancer Institute, Detroit
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecrutandoFase 3
- Wayne State University/Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
RecrutandoFase 1
- Karmanos, Detroit
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
Recrutando
- Karmanos Cancer Institute, Detroit
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RecrutandoEstudo observacional
- Karmanos Cancer Institute, Detroit
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
RecrutandoFase 1/2
- Karmanos Cancer Institute, Detroit
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
RecrutandoFase 1/2
- Barbara Ann Karmanos Cancer Institute, Detroit
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RecrutandoFase 3
- Henry Ford Health Saint John Hospital, Detroit
A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
Recrutando
- Henry Ford Health, Detroit
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RecrutandoFase 1/2
- Research Site 129, Detroit
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecrutandoFase 3
- Wayne State University/Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
Ensaios de Câncer de Próstata em outras cidades
- New York City, NY103 estudos
- Houston, TX76 estudos
- Los Angeles, CA61 estudos
- Boston, MA59 estudos
- St. Louis, MO46 estudos
- Chicago, IL45 estudos
- San Francisco, CA45 estudos
- Philadelphia, PA44 estudos
- Baltimore, MD43 estudos
- Nashville, TN43 estudos
- Seattle, WA42 estudos
- Washington, DC38 estudos
Outros estudos em Detroit
- Câncer de Pulmão de Não Pequenas Células44 estudos
- Câncer de Mama33 estudos
- Câncer (todos os tipos)29 estudos
- Câncer Colorretal26 estudos
- Câncer de Ovário26 estudos
- Câncer Metastático24 estudos
- Câncer Endometrial21 estudos
- Câncer de Pulmão20 estudos
- Mieloma Múltiplo19 estudos
- Câncer de Estômago16 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço15 estudos
- Leucemia Mieloide Aguda14 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.